In ₹ Crore except Per Share 12 Months Ending | Q1 FY26 30/06/2025 | Q2 FY26 30/09/2025 | Q3 FY26 31/12/2025 | Q4 FY26 31/03/2026 | Q1 FY27 30/06/2026 | |
|---|---|---|---|---|---|---|
| Revenue from Operations | 332.6 | 528.8 | 658.9 | 725.6 | 548.5 | |
| Other Income | 0.1 | 0.5 | 2.1 | 1.9 | 1.3 | |
| Total Income | 332.7 | 529.3 | 660.9 | 727.5 | 549.8 | |
| Expenses | ||||||
| + Cost of Materials Consumed | 284.5 | 441.2 | 649.7 | 671.1 | 567.2 | |
| + Purchases of Stock-in-Trade | 46.5 | 45.9 | 59.7 | 66.6 | 70.6 | |
| + Changes in Inventories | -46.9 | -2.7 | -105.2 | -76.7 | -146.3 | |
| + Employee Benefit Expense | 3.4 | 4.0 | 3.5 | 5.0 | 4.5 | |
| + Finance Costs | 2.3 | 2.3 | 1.3 | 1.7 | 2.1 | |
| + Depreciation & Amortisation | 0.7 | 0.8 | 0.9 | 1.1 | 1.3 | |
| + Other Expenses | 3.9 | 7.8 | 11.0 | 14.8 | 3.5 | |
| Total Expenses | 294.4 | 499.3 | 620.9 | 683.6 | 502.9 | |
| EBITDA | 41.2 | 32.6 | 40.2 | 44.7 | 48.9 | |
| EBIT | 40.5 | 31.8 | 39.3 | 43.6 | 47.6 | |
| Profit | ||||||
| PBT before Exceptional Items | 38.3 | 30.1 | 40.0 | 43.9 | 46.9 | |
| Pretax Income | 38.3 | 30.1 | 40.0 | 43.9 | 46.9 | |
| + Current Tax | 10.0 | 7.4 | 10.1 | 9.6 | 12.3 | |
| + Deferred Tax | -0.2 | -0.2 | -0.2 | 0.3 | 0.6 | |
| Tax Expense | 9.7 | 7.2 | 9.9 | 9.9 | 12.9 | |
| Net Income | 28.5 | 22.8 | 30.1 | 34.0 | 34.0 | |
| + Net Income — Continuing Ops | 28.5 | 22.8 | 30.1 | 34.0 | 34.0 | |
| + Other Comprehensive Income | -0.0 | 0.0 | 0.0 | 0.1 | 0.0 | |
| Total Comprehensive Income | 28.5 | 22.9 | 30.1 | 34.1 | 34.0 | |
| Per Share | ||||||
| Basic EPS | 3.95 | 2.99 | 3.13 | 3.53 | 3.53 | |
| Diluted EPS | 3.95 | 2.99 | 3.13 | 3.53 | 3.53 | |
| Other Comprehensive Income — detail | ||||||
| + Other Comprehensive Income | -0.0 | 0.0 | 0.0 | 0.1 | 0.0 | |
| + Items NOT to be Reclassified to P&L | -0.0 | 0.0 | 0.0 | 0.1 | 0.0 | |
| Per Share — as-filed variants | ||||||
| Basic EPS — Continuing Operations | 3.95 | 2.99 | 3.13 | 3.53 | 3.53 | |
| Diluted EPS — Continuing Operations | 3.95 | 2.99 | 3.13 | 3.53 | 3.53 | |
| Regulatory Disclosures — filed alongside, not part of the P&L | ||||||
| Related-party Transactions — During the Period | — | 5.1 | — | 2.6 | — | |
| Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories) | ||||||
| Gross Profit | 48.5 | 44.4 | 54.7 | 64.5 | 57.0 | |
| Gross Margin % | 14.58 | 8.40 | 8.30 | 8.89 | 10.39 | |
| Adjusted (ex-Exceptional Items) — derived | ||||||
| Pretax Income (Adjusted, as filed) | 38.3 | 30.1 | 40.0 | 43.9 | 46.9 | |
| Net Income Adj (tax-effected) | 28.5 | 22.8 | 30.1 | 34.0 | 34.0 | |
| EPS Adj | 3.95 | 2.99 | 3.13 | 3.53 | 3.53 | |
| Other Filed Concepts — mapped but not yet placed in the schedule | ||||||
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | |
| Paid Up Equity Capital | 7.2 | 96.4 | 96.4 | 96.4 | 96.4 | |